Bargains may be thin on the ground but there are good opportunities, says one CEO
Living longer brings with it a host of challenges
Hunt for treatments and vaccines puts spotlight on pharmaceutical companies
Trends in the sector signal a more personalised, data-driven future
‘The health market is in a state of upheaval,’ says Vigeo Eiris
Three new Ucits funds will focus on opportunities created by innovations in AI, healthcare and clean water
Pharmaceuticals used to dominate healthcare sector, but focus has shifted towards innovation and disruption
On the surface, Asia lags miles behind the west on key ESG issues – but the region is developing fast.
In the decade since the financial crisis, pharmaceuticals, healthcare and bioscience-focused funds have significantly outperformed the MSCI World index.
Not one to mince his words, when Donald Trump used his first press conference since being elected to accuse the pharmaceutical industry of “getting away with murder” it looked like the US drug industry didn’t have the respite they were expecting when Hillary Clinton was pipped to the post.